Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
With a market cap of 2.8B, Apellis Pharmaceuticals(APLS) trades at $22.12. The stock has a price-to-earnings ratio of 72.65.
On 2026-02-18, Apellis Pharmaceuticals(APLS) stock traded between a low of $21.59 and a high of $22.14. Shares are currently priced at $22.12, which is +2.5% above the low and -0.1% below the high.
Apellis Pharmaceuticals(APLS) shares are trading with a volume of 251.75K, against a daily average of 2.09M.
During the past year, Apellis Pharmaceuticals(APLS) stock moved between $16.10 at its lowest and $30.48 at its peak.
During the past year, Apellis Pharmaceuticals(APLS) stock moved between $16.10 at its lowest and $30.48 at its peak.
APLS News
In trading on Tuesday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) crossed below their 200 day moving average of $46.52, changing hands as low as $46.0...
Analyst ratings
64%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.